13C-urea breath test for success of Helicobacter pylori eradication: Study of 5885 Israeli patients

Digestive Diseases and Sciences

Volumn 50, Issue 8, 2005, Pages 1513-1516

  Niv, Y ^a   Koren, R ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

13C urea breath test; Eradication therapy; Helicobacter pylori

Indexed keywords

AMOXICILLIN; BISMUTH; CARBON 13; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE; UREA; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ADULT; AFRICA; AGED; ANAMNESIS; ARTICLE; ASIAN; CONTROLLED STUDY; DRUG USE; DUODENUM ULCER; ERADICATION THERAPY; ETHNIC GROUP; EUROPEAN AMERICAN; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; PATIENT; PEPTIC ULCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SYMPTOM; TREATMENT FAILURE; UREA BREATH TEST; ADOLESCENT; BREATH ANALYSIS; CHILD; DRUG COMBINATION; INFANT; MIDDLE AGED; PRESCHOOL CHILD; RETREATMENT; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BREATH TESTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFANT; ISRAEL; MALE; MIDDLE AGED; RETREATMENT; RISK FACTORS; TREATMENT FAILURE;

EID: 22844446262     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2870-8     Document Type: Article

References (20)

1. Everhart JE: Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 29:559-578, 2000
2. Williams MP, Pounder RE: Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol 94 (Suppl):s11-s16, 1999
3. Savarino V, Vigneri S, Celle G: The 13C urea breath test in the diagnosis of Helicobacter pylori infection. Gut 45 (Suppl 1):118-122, 1999
4. Novis BH, Gabay G, Naftali T: Helicobacter pylori: the Middle East scenario. Yale J Biol Med 71:135-141, 1998
5. Samra Z, Shmueli H, Niv Y, Dinari G, Ofek I, Passaro DJ, Geler A, Gal E, Fishman M, Bachor J, Yahav J: Resistance of Helicobactor pylori isolates in Israel to metronidazole, Clarithromytcin, tetracycline, amoxicillin and cefoxime. J Antimicrob Chemother 46:1023-1026, 2002
6. Logan RP: Urea breath tests in the management of Helicobacter pylori infection. Gut 43 (Suppl 1):s47-s50, 1998
7. Perri F, Clemente R, Pastore M, Quitadamo M, Festa V, Bisceglia M, Li Bergoli M, Lauriola G, Leandro G, Ghoos Y, Rutgeerts P, Andriulli A: The 13C urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand J Clin Lab Invest 58:19-27, 1998
8. Sheu BS, Lee SC, Yang HB, Lin XZ: Quantitative results of 13C urea breath test at 15 minutes may correlate with the bacterial density of H. pylori in the stomach. Hepatogastroenterology 46:2057-2062, 1999
9. Hawtin PR: Serology and urea breath test in the diagnosis of H. pylori infection. Mol Biotechnol 11:85-92, 1999
10. Cutler AF, Prasad VM: Long term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol91:85-88, 1996
11. Perez-Perz GI, Culter AF, Blaser MJ: Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection. Clin Infect Dis 25:1038-1043, 1997
12. Peterson WL, Graham DY: Helicobacter pylori. In Sleisenger & Fordtran's Gastrointestinal and Liver Disease, 6th ed. W. B. Saunders, Philadelphia, 1998, pp 604-619
13. Malfertheiner P, Megraud F, O'Morain C, Hungin APS, Jones R, Axon A, Graham DY, Tytgat G: The European Helicobacter Study Group, Maastricht II, 2000. Aliment Pharmacol Ther16:167-180, 2001
14. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 339:1869-1874, 1998
15. Annibale B, D'Ambra G, Luzzi I, Marcheggiano A, Lannoni C, Paoletti M, Anania MC, Marignani M, Dell Fave G: Does pre-treatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients? Am J Gastroenterol 92:790-794, 1997
16. Moayyedi P, Chalmers DM, Axon AT: Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 32:24-27, 1997
17. Perri F, Villani MR, Festa V, Quitadamo M, Andriulli A: Predictors of failure of Helicobacter pylori eradication with the standard "Maastricht triple therapy." Aliment Pharmacol Ther 15:1023-1029, 2001
18. Fireman Z, Segal A, Moshkowitz M, Kopelman Y, Sterenberg A: Helicobacter pylori and peptic disease therapies: a survey of gastroenterologists in Israel. Helicobacter 3:93-96, 1998
19. Avidan B, Weiss B, Chowers Y, Younash A, Bar-Meir S, Keler N: Sensitivity and resistance of Helicobacter pylori to antibiotic treatment. Harefuah 137:272-274, 1999
20. Weisfeld AS, Simmons DE, Vance PH: In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from the multicenter United States clinical trials. Gastroenterology 110:A295, 1996 (abstr)